Malignancy is one of the risk factors for the development of thromboembolic disease (TED). Venous thromboembolism is considered the second most common cause of death in cancer patients, with the top cause being the cancer itself. Therefore, optimal treatment and timely prevention of these complications is very important.
Don‘t have an account? Create new account
Enter the email address that you registered with. We will send you instructions on how to set a new password.
